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Objective: To evaluate the in vitro anticancer activity of crude ethyl acetate extracts of
the culture of four marine-derived fungi Aspergillus similanensis KUFA 0013 (E1),
Neosartorya paulistensis KUFC 7897 (E2), Neosartorya siamensis KUFA 0017 (E4) and
Talaromyces trachyspermus KUFC 0021 (E3) on a panel of seven human cancer cell
lines.
Methods: Effects on cell proliferation, induction of DNA damage and cell death were
assessed by MTT and clonogenic assays, comet assay and nuclear condensation assay,
respectively.
Results: The proliferation of HepG2, HCT116 and A375 cells decreased after incubation
with the extracts E2 and E4. The anti-proliferative effect was conﬁrmed by morphologic
alterations and by clonogenic assay. Both extracts also induced cell death in HepG2 and
HCT116 cells. Doxorubicin was used as a positive control and showed in vitro anticancer
activity.
Conclusions: This study demonstrated, for the ﬁrst time, that extracts of Neosartorya
paulistensis and Neosartorya siamensis have selective anti-proliferative and cell death ac-
tivities inHepG2,HCT16andA375cells.Thebioactivityof these extracts suggests a potential
for biotechnological applications and substantiates that both should be further considered for
the elucidation of the molecular targets and signal transduction pathways involved.1. Introduction
Cancer is one of the main causes of death worldwide. In the
following decades, the number of people with cancer will
continue to increase, largely due to lifestyle, nutrition and
environmental conditions in developed countries [1–3]. During
cancer development, cells acquire several genetic and
epigenetic changes. These changes result in the progressiveacquisition of biological characteristics such as sustained
proliferative signaling, insensitivity to growth suppressors,
evading apoptosis, increasing genomic instability, activating
mobility, invasion, metastasis and angiogenesis that may thus
evolve into a malignant phenotype [4].
Advances in cancer biology knowledge have allowed the
development of new treatment strategies, including new anti-
cancer drugs that may act in one or more of the hallmarks
described above. In fact, compounds that reactivate cell death
and/or decrease proliferative ability in cancer cells show a po-
tential anticancer activity. However, most of the anticancer
drugs currently used, such as doxorubicin, give rise to undesir-
able side effects, such as cardiotoxicity and tumor drug-
resistance [5]. Therefore, new anticancer drugs with more
efﬁciency and ability to mitigate side effects are in need.open access article under the CC BY-NC-ND
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in cancer treatment are from natural origin, mainly from plant
sources [6]. Nonetheless, the marine environment represents
about 95% of the world's biosphere and is an important
source of bioactive compounds to be explored [7,8]. As
terrestrial microorganisms have proved their value as sources
of bioactive compounds, the focus has also turned to marine
microorganisms [9]. Marine fungi have remained until
recently much less studied than terrestrial fungi, nevertheless,
novel metabolites have been found in marine fungi that
greatly differ from those found in terrestrial counterparts [6].
The production of secondary metabolites by marine fungi can
be inﬂuenced by the combination of the unique conditions of
marine environment, such as variations in temperature, light,
water current, salinity, and nutrient availability, all of which
create a highly competitive environment and thus force
marine organisms to evolve complex chemical adaptations,
many of which developed under a symbiotic relationship
with other species [10]. In fact, recent research has exploited
these symbiotic relationships in marine ecosystems as a
source for bioactive compounds. This is particularly pertinent
when analyzing the case of microbe-sponge relationships,
and whereas sponges are known to be notable sources for
bioactive compounds, where origin has also been attributed to
the sponge's microbial associates, namely fungi and bacteria
[11]. Furthermore, compounds are frequently produced as a
chemical manner of defense by many marine organisms, and
are released into the water and thus diluted. Consequently,
these compounds must be extremely efﬁcient in order to
produce their effect in spite of their dilution in the water.
Hence, these metabolites seem to have interest as novel lead
structures for the synthesis of new bioactive compounds
[9,12,13].
In regard to biological activity, several metabolites produced
by marine-derived fungi have been reported as antibacterial,
antiviral, antifungal, antioxidant and anticancer agents [14–17].
Notwithstanding the increasing interest in these bioactive
compounds, there is frequently an effective difﬁculty in
extracting these compounds from nature since their source
organisms are often hard to reproduce and manipulate in
laboratorial conditions, limiting their availability and use.
Interestingly, some marine fungi may grow efﬁciently under
laboratory conditions, which may therefore enable the use of
biotechnological tools for a massive production of the
compounds of interest [18,19]. In summary, marine-derived
fungi seem to be good candidates as a source of new bioactive
compounds, thus making them a pivotal part of the emergent
marine biotechnology applications.
Our present purpose was to assess the in vitro anticancer
activity of crude ethyl acetate extracts of the sponge-derived
fungi Aspergillus similanensis (A. similanensis) KUFA 0013
(E1), Neosartorya paulistensis (N. paulistensis) KUFC 7897
(E2) and Talaromyces trachyspermus (T. trachyspermus)
KUFC 0021 (E3), and the sea fan-derived fungi Neosartorya
siamensis (N. siamensis) KUFA 0017 (E4), on a panel of
seven human cancer cell lines, namely, colorectal carcinoma
(HT29 and HCT116), hepatocellular carcinoma (HepG2),
breast adenocarcinoma (MCF-7), malignant melanoma (A375),
non-small cell lung carcinoma (A549) and glioblastoma
(U251) cells. The chemical composition of the ethyl extracts
E1, E2 and E3 has been previously analysed by members of
our research team [20–22].2. Materials and methods
2.1. Chemicals
Doxorubicin, DMEM, MEM, RPMI-1640, sodium pyruvate,
sodium bicarbonate, N-(2-hydroxyethyl)piperazine-N0-(2-
ethanesulfonic acid), penicillin/streptomycin, trypsin solution,
3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide
(MTT) and 4,6-diamidino-2-phenylindole (DAPI) were pur-
chased from Sigma–Aldrich (St. Louis, MO, USA). Fetal bovine
serum was purchased from Biochrom KG (Berlin, Germany).
All other reagents and chemicals used were of analytical grade.
2.2. Fungal material
A. similanensis KUFA 0013 was isolated from the marine
sponge Rhabdermia sp., as described by Prompanya et al [22],
N. paulistensis KUFC 7897 was isolated from the marine
sponge Chondrilla australiensis, as previously reported [20],
and T. trachyspermus KUFC 0021 was isolated from the
marine sponge Clathria reianwardii, as reported by Kumla
et al [21].
N. siamensis KUFA 0017 was isolated from sea fan (Rum-
phella sp.), collected from the coral reef at Similan island, Phang
Nga province, Southern Thailand, in April 2010. Brieﬂy, the sea
fan tissue was cut into a piece of 0.5 cm × 0.5 cm, placed on the
malt extract agar (MEA) with 70% sea water and incubated for
28 C for 7 d. The fungus was identiﬁed by one of us (T.
Dethoup) by morphological features, including the characteristic
of ascospores and colonies, and by sequence analysis of the b-
tubulin gene [23]. The pure cultures were deposited as
KUFA0017 at Kasetsart University Fungal Collection,
Department of Plant Pathology, Faculty of Agriculture,
Kasetsart University, Bangkok, Thailand.
2.3. Preparation of crude ethyl acetate extracts from
marine-derived fungi
A. similanensis KUFA 0013, N. paulistensis KUFC 7897 and
T. trachyspermus KUFA 0021 were cultured as described by
Prompanya et al [22], Gomes et al [20] and Kumla et al [23],
respectively. Brieﬂy, the fungi were cultured for one or two
weeks in Petri dishes with malt extract agar. Erlenmeyer
ﬂasks, containing rice and water, were autoclaved at 121 C
for 15 min and then inoculated with mycelia plugs of the
fungi and incubated at 28 C for 30 d, after which the moldy
rice was macerated in ethyl acetate and ﬁltered. The two
layers were separated, and the ethyl acetate solution was
concentrated at a reduced pressure to yield 97.51 and 102.00 g
of the crude ethyl acetate extracts, respectively [21,22].
N. siamensis KUFA 0017 was cultured for one week in Petri
dishes with 25 mL of potato dextrose agar per dish. Thirty-ﬁve
Erlenmeyer ﬂasks containing 200 g of rice and 100 mL of water
were autoclaved at 121 C for 15 min, and then inoculated with
10 mycelium plugs of the fungus. The culture was incubated at
28 C for 30 d. To each ﬂask with the mouldy rice was added
500 mL of ethyl acetate and the content was left to macerate for
7 d. The content of the ﬂasks was ﬁltered by ﬁlter paper and the
ﬁltrate was evaporated under reduced pressure to give 1000 mL
of the solution and then anhydrous sodium sulphate was added
and ﬁltered. The ethyl acetate solution was evaporated under
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crude ethyl acetate extract.
2.4. Cell culture
Seven human cancer cell lines were used to assess anti-
proliferative activity. HT29 and HCT116 (colorectal carci-
noma) were kindly provided by Prof. Carmen Jero´nimo from CI-
IPO, Porto. HepG2 cells were kindly provided by Prof. Rosa´rio
Martins from ESTSP and CIIMAR, Porto. MCF-7, A375, A549
and U251 cells were obtained from European Collection of Cell
Cultures (ECACC). Human cancer cell lines were maintained as
monolayer cultures in DMEM (HT29, A375 and A549), MEM
(HepG2, MCF-7 and U251) and RPMI (HCT116), supple-
mented with 10% fetal bovine serum and 1% of antibiotic so-
lution (100 U/mL penicillin and 100 mg/mL streptomycin),
0.1 mmol/L sodium pyruvate and 10 mmol/L N-(2-
hydroxyethyl)piperazine-N0-(2-ethanesulfonic acid) under an
atmosphere of 5% CO2 at 37 C. Cells were trypsinized when
nearly conﬂuent.
Stock solutions of Dox and crude ethyl acetate extracts of the
marine fungi were prepared in dimethyl sulphoxide (DMSO)
and aliquots kept at −20 C. The ﬁnal concentration of DMSO in
the medium was <0.5% (v/v). The controls received only
DMSO. All the cells were incubated with the extracts and Dox
dissolved in RPMI just before use, in order to maintain the same
conditions for all cell lines.
2.5. MTT reduction assay
To evaluate the effects of the crude ethyl acetate extracts on
cell viability/proliferation, cells were plated in 96-multiwell
culture plates at a density of 0.8 × 104 – 1 × 104 cells/well.
Twenty-four hours after plating, the medium was discarded and
fresh medium containing the extracts of the marine-derived
fungi at different concentrations (0.1–500.0 mg/mL) and Dox
at (0.001–10.000 mmol/L) as positive control, as well as 0.5%
DMSO as negative control was added. After 48 h incubation
with the extracts, MTT was added at a ﬁnal concentration of
0.5 mg/mL and incubated for 2 h. Then, the medium was
removed, and the formazan crystals were dissolved in a
DMSO:ethanol solution (1:1) (v/v). Absorbance was measured
at 570 nm in a microplate reader (Multiskan EX, Labsystems,
USA). The MTT colorimetric assay is based on mitochondrial
conversion of tetrazolium salt (MTT) into formazan crystals, and
thus alterations in the number of viable cells can be detected by
measuring formazan crystals optical density [24,25]. IC50
corresponds to the concentration of the extract or Dox that
decreases the number of viable cells by 50%. In this case, the
absorbance in the control at 48 h corresponds to 100%
viability. The IC50 values were determined using GraphPad
Prism v5.0 software (GraphPad Software, La Jolla, CA, USA).
To evaluate the effect on cell proliferation, the absorbance at
the beginning of incubation (t = 0 h) was subtracted from all
the experimental conditions used, including the control (0.5%
DMSO) at 48 h. Therefore, negative values can be interpreted
as direct and short-term cytotoxic effect of the extracts that
may, in turn, indicate necrotic cell death [26]. Positive values
(between 0 and 100%) can be interpreted as inhibition of cell
proliferation. This variant of the MTT assay allows a rapid
and simple discrimination between inhibition of cell
proliferation and cell death [26]. The results are expressed asthe percentage of cell viability/proliferation relative to control
(untreated cells) of at least six independent experiments; each
one was carried out in duplicate. For the following assays,
only the fungal extracts that presented an IC50 equal to or less
than the arbitrary cut-off threshold of 200 mg/mL and without
direct cytotoxic effects were used.
2.6. Clonogenic assay
To study the effect of the extracts of the marine-derived fungi
on the proliferation of clonogenic cells, cells were plated
(1 × 105 cells/well) in 24-multiwell culture plates and treated
with extracts or Dox (IC50). After a 48 h treatment, survival cells
were trypsinized, counted and plated in 6-multiwell culture
plates at 200 cells/well with fresh medium. After 10 d of culture,
colonies were ﬁxed, stained with crystal violet (5 g/mL) for
30 min and washed with water. Colonies containing more than
50 individual cells were counted using a stereomicroscope
(Leica, ZOOM 2000). Plating efﬁciencies (PE) were calculated
from the ratio between the number of colonies counted and the
number of cells plated. The surviving fraction (SF) was calcu-
lated using the formula: SF = PE of treated cells/PE of con-
trol × 100 [27–29]. Results are expressed as the surviving fraction
relative to control (cells treated with 0.5% DMSO).
2.7. Comet assay
To investigate the genotoxic effect of the tested fungal ex-
tracts, cells were plated (1 × 105 cells/well) in 24-multiwell
culture plates. Twenty-four hours after plating, cells were
incubated with the extracts of the marine-derived fungi (IC50) for
4, 24 and 48 h and DNA damage (strand breaks and alkali-labile
sites) was assessed by the alkaline version of the single cell gel
electrophoresis (comet) assay [30,31]. In short, after treatment,
cells were trypsinized, washed and centrifuged, and the pellet
suspended in low melting point agarose and about
2 × 104 cells/gel were placed on a slide pre-coated with 1%
normal melting point agarose. Slides were placed in lysis solu-
tion (2.5 mol/L NaCl, 100 mmol/L Na2EDTA, 10 mmol/L Tris
base, pH 10 plus 1% Triton X-100) for 1 h at 4 C, and then
placed in a horizontal electrophoresis chamber with a buffered
solution (300 mmol/L NaOH, 1 mmol/L Na2EDTA, pH > 13),
for 40 min at 4 C, for the DNA to unwind. The electrophoresis
was run at 21 V for 20 min and the slides were washed twice
with PBS and dried at room temperature. For the analysis of the
comet images, the slides were stained with DAPI solution (1 mg/
mL) and visualized in a ﬂuorescence microscope (Olympus
IX71). Images were registered and studied with the image
analysis software CometScore® (CometScore, TriTek Corp.), for
quantifying the percentage of tail intensity. At least 100
randomly selected cells were analyzed per sample.
2.8. Nuclear condensation assay
To evaluate the ability of the extracts of the marine-derived
fungi to induce cell death, cells were plated (1 × 105 cells/
well) in 24-multiwell culture plates. After cell adhesion, cells
were treated with the extracts or Dox (IC50) for 48 h and nuclear
condensation was assessed by observation in the mentioned
ﬂuorescence microscope. Brieﬂy, both adherent and non-
adherent cells were collected, washed, centrifuged, ﬁxed with
4% (w/v) paraformaldehyde in PBS for 20 min at 37 C, and
Figure 1. Dose-response effects of extracts E2 (A), E4 (B) and doxoru-
bicin (C) on cell viability/proliferation in HepG2, HCT116 and A375 cells
after 48 h, evaluated by MTT assay. Results are expressed as mean ± SD of
at least six independent experiments, each made in duplicate. Signiﬁcant
differences (*P < 0.05; **P < 0.01 and ***P < 0.001) between groups per
situation of exposure were tested by one-way ANOVA, followed by the
post-hoc Newman–Keuls multiple comparison test.
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Cytocentrifuge (Thermo Scientiﬁc, USA). Once dried, slides
were incubated with DAPI (1 mg/mL) for nuclei staining. The
percentage of cells with condensed nuclei was calculated from
the ratio between cells with nuclear condensation and total
number of cells (nuclei staining with DAPI). More than 300 cells
were counted per sample.
2.9. Statistical analysis
Results are expressed as mean ± SD from at least three in-
dependent experiments. The GraphPad Prism 5.0 software
(GraphPad Software, La Jolla, CA, USA) was used for infer-
ential statistics. Eventual signiﬁcant differences (P < 0.05) were
evaluated by one-way ANOVA, followed by the post-hoc
Newman–Keuls multiple comparison test or Dunnett's test, as
appropriate. In speciﬁc cases, Student's t-test was used as
described. Data from the MTT assay were analysed for normal
distribution using the D'Agostino-Pearson omnibus test. For the
remaining data, normal distribution was not tested due to low
‘n’, and was assumed to occur, which is consistent with the
normal behavior of cell culture responses as observed in similar
published studies.
3. Results
3.1. Effect of extracts of marine-derived fungi on cell
viability and proliferation in cancer cells by MTT
In order to test the effects of the extracts of four marine-
derived fungi on cell viability and proliferation, seven human
cancer cell lines (HT29, HCT116, HepG2, MCF-7, A375, A549
and U251) were used. The assay was performed on exponen-
tially growing cells, as previously determined (data not shown).
Each cell line was incubated for 48 h with the extracts at
different concentrations (0.1–500.0 mg/mL) and then cell
viability and proliferation were assessed by MTT assay. Doxo-
rubicin was tested in parallel over a concentration range (0.001–
10.000 mmol/L), corresponding to (5.8 × 10−4–5.8 mg/mL), as a
positive control. The IC50 (concentration of the extract or Dox
that reduces the number of viable cells by 50%) for each cell line
was calculated from the dose–response curves. The values of the
IC50 are summarized in Table 1. The extracts E2 and E4
signiﬁcantly decreased the number of viable cells in HepG2,
HCT116 and A375 cells. Both extracts showed similar IC50
values for HepG2 cells. Regarding HCT116 and A375 cells, the
extract E4 showed a lower IC50 value (124 and 150 mg/mL,Table 1
Determination of IC50 values
a (concentration that inhibits the number of v
doxorubicin as a positive control.
Cancer cell lines Doxorubicin (mmol/L) KUFA 0013 (E1) IC50
IC50 95% CI
HepG2 0.11 (0.07–0.17) >200
HT29 0.87 (0.54–1.39) >200
HCT116 0.13 (0.09–0.19) >200
U251 1.55 (0.70–2.50) >200
A549 0.54 (0.30–0.94) >200
A375 0.12 (0.09–0.16) >200
MCF7 0.37 (0.27–0.50) >200
a IC50 values are the mean of at least six independent experiments, each inrespectively) when compared to the extract E2 (165 and 184 mg/
mL). The extracts E1 and E3 had an IC50 higher than the cut-off
level of 200 mg/mL in all tested cell lines, and therefore they
were not used in the following experiments. Dox decreased cell
viability in all tested cell lines and the related IC50 values rangediable cells in 50%) of four extracts (mg/mL) in seven cells lines, with
KUFC 7897 (E2) KUFC 0021 (E3) IC50 KUFA 0017 (E4)
IC50 95% CI IC50 95% CI
198 (179–208) >200 197 (182–213)
>200 >200 >200
165 (136–201) >200 124 (81–180)
>200 >200 >200
>200 >200 >200
184 (160–209) >200 150 (131–173)
>200 >200 >200
duplicate.
Figure 2. Morphology of HepG2 cells under phase contrast, after 48 h incubation with A) 0.5% of DMSO, B) Dox, C) extract E2, and D) extract E4, all
three at IC50. Situation A) represents control cells, with normal morphology. In B), C) and D) arrows indicate rounded and detaching cells. Scale
bar = 10 mm.
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(Table 1).
In relation of cell proliferation, it was observed that all cell
lines, when treated only with 0.5% DMSO (negative control),
grew signiﬁcantly between the beginning (t = 0 h) and the end of
the incubation (t = 48 h) (data not shown). The results showed
that the extracts E2 and E4 decreased cell proliferation in a
concentration-dependent manner in HepG2, HCT116 and
A375 cells (Figure 1). The anti-proliferative effect of both ex-
tracts was higher in HCT116 and A375 cells. The extract E2, at
100 mg/mL, signiﬁcantly decreased proliferation of HCT116 andFigure 3. Clonogenic survival of HepG2 (A), HCT116 (B) and A375 (C) cells
followed by 10 d in fresh medium. Results are expressed as mean ± SD of a
**P < 0.01 and ***P < 0.001) when compared with control cells were eval
Representative images of clonogenic assay in HepG2 cells after pre-treatment
showing a decrease of the number of colonies formed relative to control (a).A375 cells by 43% and 25%, respectively relative to control
(Figure 1A). At the same concentration, the extract E4 signiﬁ-
cantly decreased proliferation of HCT116 and A375 cells by
72% and 60%, respectively (Figure 1B). In the MTT assay, the
extract E4 was more active in the cells lines tested. For con-
centrations higher than 200 mg/mL, both extracts showed a
direct cytotoxic effect in HepG2, HCT116 and A375 cells. Dox
decreased cell proliferation in a concentration-dependent manner
in all cell lines tested. At 1 and 10 mmol/L, Dox exhibited a
direct cytotoxic effect in HepG2, HCT116 and A375 cells
(Figure 1C).after pre-treatment with extracts E2, E4 and Dox (all three at IC50) for 48 h,
t least three independent experiments. Signiﬁcant differences (*P < 0.05;
uated by one-way ANOVA, followed by the post-hoc Dunnett's test. D)
with a) 0.5% of DMSO, b) extracts E2, c) extract E4 and d) Dox at IC50,
Figure 4. Effect of extracts E2, E4 and Dox (all three at IC50) on DNA
damage (strand breaks and alkali-labile sites) after 48 h in HepG2, HCT116
and A375 cells, assessed by comet assay.
Values are mean ± SD of at least three independent experiments. Signiﬁcant
differences (*P < 0.05) when compared with control cells were judged by
one-way ANOVA, followed by the post-hoc Dunnett's test. Additionally, a
Student's t-test was selectively used to access signiﬁcant differences in
HepG2 (E2) and A375 (Dox) in relation to the respective control.
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experiments, two aspects were considered: 1) extracts should
inhibit cell proliferation without signiﬁcant direct cytotoxic ef-
fects; and 2) the IC50 value of the extract should be lower than
200 mg/mL. Having met these two criteria, the extracts E2 and
E4 were selected, and the anti-proliferative and pro-cell death
effects were evaluated in HepG2, HCT116 and A375 cells.
The anti-proliferative effect of the extracts E2, E4 and Dox in
HepG2, HCT116 and A375 was also conﬁrmed by a decrease of
cell density and also by structural alterations, such as rounded
and detached cells as observed in a phase contrast microscope
(Figure 2).
3.2. Effect of extracts of marine-derived fungi on
reproductive viability by clonogenic assay
To evaluate the long-term anti-proliferative effects of the
extracts, cells were pre-treated for 48 h with the extracts (IC50)
and then survival cells were allowed to grow for 10 d in freshFigure 5. Effect of extracts E2, E4 and Dox (all three at IC50) on the induction
the nuclear condensation assay after 48 h of incubation.
Values are mean ± SD of at least three independent experiments. Signiﬁcant di
were determined by one-way ANOVA, followed by the post-hoc Dunnett's t
exposure to a) 0.5% of DMSO, b) extracts E2, c) extract E4 and d) Dox at ICmedium without extracts. Results from the clonogenic survival
assay showed that the extract E2 signiﬁcantly decreased the
proliferative ability of a single cell to form a viable colony in
HepG2, HCT116 and A375 cells (Figure 3). The extract E4
signiﬁcantly reduced the number of colonies in HepG2 and
HCT116 cells when compared with control (cells pre-treated
with 0.5% DMSO) (Figure 3A and B). Meanwhile, no signiﬁ-
cant results were observed in A375 cells (Figure 3C). Cells pre-
treated with Dox did not show an ability to proliferate and form
colonies.
3.3. Evaluation of the effect of the extracts of the marine-
derived fungi on DNA damage by the comet assay
To assess the genotoxic effect of the extracts, cells were
incubated with extracts at the IC50 concentration for 4, 24 and
48 h, and DNA damage (strand breaks and alkali-labile sites)
was assessed by the comet assay. Results are expressed as the
percentage of DNA in tail. At 4 and 24 h of incubation, none of
the extracts at the tested concentrations induced DNA damage in
HepG2, HCT116 or A375 cells (data not shown). However, after
incubation for 48 h, the extract E2 signiﬁcantly increased by
16% the extent of DNA damage in the HepG2 cells (see white
bars, Figure 4), when compared with control cells (0.5%
DMSO). No effect was observed in HCT116 (grey bars) and
A375 (black bars) cells when treated with the extract E2.
Moreover, the extract E4 did not induce DNA damage detectable
by the comet assay at any of the tested experimental conditions.
However, at 48 h, Dox evidenced a signiﬁcant increase of DNA
damage in HCT116 (by 25%) and A375 (by 9%) cells, when
compared to the control (Figure 4).
3.4. Effects of extracts of marine-derived fungi on cell
death by nuclear condensation assay
Since the anti-proliferative effects of the extracts could be
due to cell death, we evaluated nuclear condensation after 48 h
cell incubation with the extracts (at IC50). As shown in Figure 5,
the extract E2 signiﬁcantly induced nuclear condensation inof nuclear chromatin condensation in HepG2 (A) and HCT116 cells (B) by
fferences (**P < 0.01 and ***P < 0.001) when compared with control cells
est. Representative images of nuclear condensation in HCT116 cells after
50. Scale bar = 100 mm. Nuclear condensation (arrow).
Alice Abreu Ramos et al./Asian Paciﬁc Journal of Tropical Medicine 2015; 8(10): 798–806804HepG2 (Figure 5A) and HCT116 cells (Figure 5B). The number
of cells with condensed nuclei was increased by 9% in HepG2
and 24% in HCT116 cells. The extract E4 also induced an in-
crease of nuclear condensation by 9% in HepG2 and 16% in
HCT116 cells. Dox induced nuclear condensation also by 10%
in HepG2 and by 8% in A375 cells. However, none of the tested
extracts induced an increase of cells with nuclear condensation
in A375 cells (data not shown). The HCT116 cells were the most
sensitive to cell death induction by the extracts, with the extract
E2 being the most effective against this cancer cell line.
4. Discussion
Marine-derived fungi biosynthesize a vast range of secondary
metabolites with complex and unique structures [32]. However,
very little is known about the biological activity of the
extracts and compounds of these fungi. In this study, we
investigated the in vitro anticancer activity of the crude ethyl
acetate extracts obtained from four marine-derived fungi,
A. similanensis (E1), N. paulistensis (E2), T. trachyspermus (E3)
and N. siamensis (E4), on seven human cancer cell lines.
To the best of our knowledge, this is the ﬁrst report on the
in vitro anticancer activity of the marine-derived fungi
N. paulistensis KUFC 7897 (E2) and N. siamensis KUFA 0017
(E4). In this study we showed that extracts E2 and E4 decrease
the number of viable cells, with an IC50 lower than 200 mg/mL
in HCT116, A375 and HepG2 cells. Both extracts decreased cell
proliferation in a dose-dependent manner and exhibited a direct
cytotoxic effect in HepG2, HCT116 and A375 cells at concen-
trations greater than 200 mg/mL. Some authors refer that intense
insults (exposure to high concentrations) are able to induce
uncontrolled cell death (necrosis) [33]. The extract E3 did not
exhibit signiﬁcant anticancer bioactivity (IC50 > 200 mg/mL)
in the tested panel of cell lines. Several compounds of the
ethyl acetate extract of T. trachyspermus KUFA 0021 (E3)
have been isolated by Kumla et al [21], namely, 3-acetyl ergos-
terol 5,8-endoperoxide, ergosta-4,6,8(14),22-tetraen-3-one, spi-
culisporic acid E, glaucanic and glauconic acid. The latter three
were tested for cytotoxic activity against breast MCF-7, lung
NCI–H460 and melanoma A375-C5 cancer cell lines, however,
did not present signiﬁcant bioactivity [21], much alike to our
crude ethyl acetate extract. Similarly, the assessment of
anticancer bioactivity of the crude extract of A. similanensis
(E1) did not result in an observation of meaningful cytotoxic
activity (IC50 > 200 mg/mL) against our panel of cell lines.
The chemical composition of A. similanensis KUFA 0013
(E1) ethyl acetate extract was described by Prompanya et al
[22], and resulted in the isolation of ﬁve compounds, chevalone
E, pyripyropene S, 5-hyroxy-8-methyl-2H, 6H-pyrano[3,4-g]
chromen-2,6-dione and 6,8-dihydroxy-3,7-
dimethylisocoumarin. After the initial screening of anti-
proliferative activity, the extracts E2 and E4 that showed an
IC50 lower than 200 mg/mL were selected for the following
studies.
The reduction of the number of viable cells could be due to
an increase of cell death and/or decreased cell proliferation. In
our study, the suggestive induction of cell death was ﬁrst noticed
through the observation of morphological alterations (cell
shrinkage, membrane blebbing, rounded and detached cells) in a
phase contrast microscope and further conﬁrmed by a nuclear
condensation assay. Moreover, to discern whether the anti-
proliferative activity prevailed over time, i.e., a cytostaticeffect, a clonogenic cell survival assay was performed to assess
the extracts' ability of arresting indeﬁnite proliferation of cells by
reducing reproductive viability [29].
In this perspective, the in vitro anticancer effect of the extract
E4 in HepG2 and HCT116 cells could be due to both an increase
of cell death and a decrease of long-term cell proliferation. In
A375 cells, the extract E4 decreased the number of viable cells
without an induction of cell death and presented a slight
decrease of clonogenic potential. In this case, the extract E4
seems to inhibit only cell proliferation in short term, however, in
long term the alterations induced by the extract seem to be
reverted or repaired in A375 malignant melanoma cells. The
lack of long-term inhibition may be explained by the observa-
tions of other studies, which have shown that malignant mela-
noma is resistant to chemotherapy based on DNA damage
induction, besides the normal function of p53, and may be
related to the up-regulation of some DNA repair genes [34,35].
The analysis of the ethyl extract of N. siamensis KUFA 0017
(E4) composition is still not available. However, Buttachon et al
have reported the isolation of several compounds from a
terrestrial strain of N. siamensis KUFC 6349, namely, sartor-
ymensin, tryptoquivaline, tryptoquivalines F, H, L and O, ﬁs-
calins A and C, epi-ﬁscalin A and C, epi-neoﬁscalin A,
neoﬁscalin A and 2,4-dihydroxy-3- methylacetophenone [36]. In
the same study, selected compounds were screened for the
in vitro cytotoxic activity in a panel of cancer cell lines, and
the results showed that sartorymensin, tryptoquivaline O and F
showed an IC50 range between 72 and 91 mmol/L in breast
MCF-7 and glioblastoma U373 cells. Additionally, Sondgam
et al showed that tryptoquivaline L, epi-ﬁscalin A and C, iso-
lated from Xylaria humosa, have cytotoxic effects in MCF-
7 cells with an IC50 range between 21 and 33.6 mg/mL [37]. If the
nature of the compounds of the marine-derived strain is similar
to that of the mentioned terrestrial counterpart, it is possible to
hypothesize that some of the referred compounds may be
responsible for the anticancer activity of the extract E4. How-
ever, further studies should be ensued to conﬁrm this hypothesis.
The in vitro anticancer activity of the extract E2 in HepG2
and HCT116 cells was mainly due to the induction of cell death
and decrease of long-term proliferation of survival cells. In
HepG2 cells, the induction of cell death could be related with the
ability of the extract E2 to induce DNA damage. This charac-
teristic is common to several chemotherapeutic drugs, which
reveal an anticancer activity mainly due to their ability to induce
DNA damage; if such DNA damage is not properly repaired, its
accumulation ultimately ensues in cell death [38]. In A375 cells,
the extract E2 decreased long-term cell proliferation (diminished
colony formation) without effects on induction of cell death, at
the tested conditions. Decrease of clonogenic survival may be
related with the induction of senescence and mitotic catastrophe
[39,40]. The analysis of the chemical composition of the ethyl
extract of N. paulistensis KUFC 7896 (E2) has been described
by Gomes et al [20], which led to the isolation of several
compounds, namely, sartorypyrone C, tryptoquivalines H, L,
F, 4(3H)-quinazolinone and 30-(4-oxoquinazolin-3-yl) spiro
[1H-indole-3,50]-2,20-dione. As referred previously, tryptoqui-
valine L exhibited cytotoxic activity against MCF-7 cells [37],
while tryptoquivaline F exhibited cytotoxic activity against
MCF-7 and U373 cells [36]. It is thus possible to suggest that
tryptoquivalines L and F, among other compounds, may be in
some measure responsible for the anticancer activity of the
extract E2.
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chemotherapy and its cytotoxic effect has been related to free
radical formation, inhibition of DNA topoisomerase II and
nucleotide intercalation, resulting in cell cycle arrest and
apoptosis [41]. In our study, the in vitro anticancer activity of
Dox, used as a positive control, seems to be related to a
decrease in long-term cell proliferation and induction of cell
death. However, in accordance with other studies, in HCT116
cells Dox reduces the number of viable cells without an induc-
tion of apoptosis [42]. Induction of cell death by Dox seems to
depend on factors such as dose, exposure time and cell line
used. Even so, facing our aims, Dox's exact mechanisms do
not jeopardize it as control.
Genetic characteristics of cells, namely p53 status, inﬂuence
its susceptibility to chemotherapy [43]. Some studies have
associated, in part, the Dox resistant phenotype with p53
status [44,45], and this can in fact be observed in our results
regarding HT29 and U251 cells, which are p53 mutant,
presenting higher IC50 values for Dox. Our results indicate
that the extracts E2 and E4 only present an effect in the p53
mutant cells (HCT116, HepG2 and A375), which suggests that
the in vitro anticancer activity of the extracts could be p53
dependent. In spite of this, it must be considered that the
response to the extract varies according to cell line, which
varies in multiple genetic factors, it is probable that other
molecular targets are involved, and thus it is pressing to
clarify the molecular mechanisms involved in the activity of
the extracts E2 and E4.
Our results reinforce the interest in pursuing further studies on
the anticancer bioactivity of extracts and compounds originating
from marine fungi from the Neosartorya genus. Some marine
fungi of the Neosartorya genus are known to produce several
compounds with the in vitro anticancer activity, for example,
Liang et al exempliﬁed ﬁve compounds (four gliotoxin analogues
and one diketopiperazine) isolated from Neosartorya pseudoﬁ-
scheri 2014F27-1 which presented cytotoxic activity against co-
lon cancer HCT116, RKO and kidney HEK 293 cell lines [46].
Tan et al isolated several compounds from Neosartorya ﬁscheri
1008F, resulting in two compounds, AGI-B4 and 3,4-
dihydroxybenzoic acid, with cytotoxic activity against gastric
SGC-7901 and hepatic BEL-7404 cancer cell lines [47].
In summary, our study shows for the ﬁrst time that the crude
ethyl acetate extracts obtained from the marine-derived fungi
N. paulistensis and N. siamensis have in vitro anticancer activ-
ities, by causing a decrease in cell proliferation and/or induction
of cell death in hepatocellular carcinoma, colon carcinoma and
melanoma cells. The inherent molecular targets and related
signal transduction pathways should be researched in the future.
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